Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions

This commentary calls for a broader use of outcome-adaptive randomisation when designing clinical trials to test multiple COVID-19 interventions, as this potentially reduces the number of deaths or other adverse outcomes incurred during a trial.


Annals of Internal Medicine